The White House is taking steps to bolster defenses against biological threats in response to concerns raised by staffing reductions during the early phase of the second Trump administration. These cuts have affected the nation’s capability to handle risks associated with AI-driven advancements in pathogen development.

Experts in public health and biodefense have highlighted the increasing potential of artificial intelligence in assisting the creation of dangerous biological agents. This technological leap has raised the alarm among officials worried about national security and public health.

Efforts to improve safeguards have faced delays, causing unease as the AI capabilities continue to evolve rapidly. The need for well-equipped teams to counter this emerging threat is more pressing than ever.